LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹38 Cr | ₹57 Cr | ₹72 Cr | ₹130 Cr | ₹162 Cr |
What is the latest Total Debt ratio of LYKA LABS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹162 Cr |
How is Total Debt of LYKA LABS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -32.99 | |
| Mar2024 | ₹57 Cr | -21.44 | |
| Mar2023 | ₹72 Cr | -44.54 | |
| Mar2022 | ₹130 Cr | -19.86 | |
| Mar2021 | ₹162 Cr | - | |
Compare Total Debt of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹255.0 Cr | -1.6% | -5.4% | -53.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -1.6% |
-5.4% |
-53.6% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses